VAXART, INC. (VXRT)
Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting
Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
Digimarc Extends Its Agent-Native Provenance and Verification Platform to the World’s Leading Agentic AI Ecosystems
Zapata Quantum Announces Uplisting to OTCQB Market
Pennymac Names AWS as Preferred Cloud Provider, Expanding Strategic Agreement to Deploy Enterprise-Grade AI and Commercialize its Servicing Platform
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
authID and Trinsic Partner to Deliver Secure and Easily Deployable Biometric-Powered Digital Identity
Global Credit Union selects NCR Atleos ATMs to support new Utqiaġvik branch in Alaska’s northernmost city
OSS Receives $8.4 Million Contract from a Leading Defense and Technology Solutions Company
Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study